Registration Dossier
Registration Dossier
Data platform availability banner - registered substances factsheets
Please be aware that this old REACH registration data factsheet is no longer maintained; it remains frozen as of 19th May 2023.
The new ECHA CHEM database has been released by ECHA, and it now contains all REACH registration data. There are more details on the transition of ECHA's published data to ECHA CHEM here.
Diss Factsheets
Use of this information is subject to copyright laws and may require the permission of the owner of the information, as described in the ECHA Legal Notice.
EC number: 947-862-2 | CAS number: -
- Life Cycle description
- Uses advised against
- Endpoint summary
- Appearance / physical state / colour
- Melting point / freezing point
- Boiling point
- Density
- Particle size distribution (Granulometry)
- Vapour pressure
- Partition coefficient
- Water solubility
- Solubility in organic solvents / fat solubility
- Surface tension
- Flash point
- Auto flammability
- Flammability
- Explosiveness
- Oxidising properties
- Oxidation reduction potential
- Stability in organic solvents and identity of relevant degradation products
- Storage stability and reactivity towards container material
- Stability: thermal, sunlight, metals
- pH
- Dissociation constant
- Viscosity
- Additional physico-chemical information
- Additional physico-chemical properties of nanomaterials
- Nanomaterial agglomeration / aggregation
- Nanomaterial crystalline phase
- Nanomaterial crystallite and grain size
- Nanomaterial aspect ratio / shape
- Nanomaterial specific surface area
- Nanomaterial Zeta potential
- Nanomaterial surface chemistry
- Nanomaterial dustiness
- Nanomaterial porosity
- Nanomaterial pour density
- Nanomaterial photocatalytic activity
- Nanomaterial radical formation potential
- Nanomaterial catalytic activity
- Endpoint summary
- Stability
- Biodegradation
- Bioaccumulation
- Transport and distribution
- Environmental data
- Additional information on environmental fate and behaviour
- Ecotoxicological Summary
- Aquatic toxicity
- Endpoint summary
- Short-term toxicity to fish
- Long-term toxicity to fish
- Short-term toxicity to aquatic invertebrates
- Long-term toxicity to aquatic invertebrates
- Toxicity to aquatic algae and cyanobacteria
- Toxicity to aquatic plants other than algae
- Toxicity to microorganisms
- Endocrine disrupter testing in aquatic vertebrates – in vivo
- Toxicity to other aquatic organisms
- Sediment toxicity
- Terrestrial toxicity
- Biological effects monitoring
- Biotransformation and kinetics
- Additional ecotoxological information
- Toxicological Summary
- Toxicokinetics, metabolism and distribution
- Acute Toxicity
- Irritation / corrosion
- Sensitisation
- Repeated dose toxicity
- Genetic toxicity
- Carcinogenicity
- Toxicity to reproduction
- Specific investigations
- Exposure related observations in humans
- Toxic effects on livestock and pets
- Additional toxicological data
![](https://echa.europa.eu/o/diss-blank-theme/images/factsheets/A-REACH/factsheet/print_toxicological-information.png)
Genetic toxicity: in vitro
Administrative data
- Endpoint:
- in vitro gene mutation study in bacteria
- Type of information:
- experimental study
- Adequacy of study:
- key study
- Study period:
- 24 Apr - 31 May 1996
- Reliability:
- 2 (reliable with restrictions)
- Rationale for reliability incl. deficiencies:
- guideline study with acceptable restrictions
Data source
Reference
- Reference Type:
- study report
- Title:
- Unnamed
- Year:
- 1 996
- Report date:
- 1996
Materials and methods
Test guidelineopen allclose all
- Qualifier:
- according to guideline
- Guideline:
- OECD Guideline 471 (Bacterial Reverse Mutation Assay)
- Version / remarks:
- adopted in 1983
- Deviations:
- no
- Qualifier:
- equivalent or similar to guideline
- Guideline:
- OECD Guideline 471 (Bacterial Reverse Mutation Assay)
- Version / remarks:
- adopted in 1997
- Deviations:
- yes
- Remarks:
- only 4 tester strains used
- GLP compliance:
- yes
- Type of assay:
- bacterial reverse mutation assay
Test material
- Reference substance name:
- Fatty acids C8-18 (even numbered), mono- and diesters with sucrose
- EC Number:
- 947-862-2
- Molecular formula:
- not applicable, substance is UVCB
- IUPAC Name:
- Fatty acids C8-18 (even numbered), mono- and diesters with sucrose
Constituent 1
Method
- Target gene:
- Histidin operon
Species / strain
- Species / strain / cell type:
- S. typhimurium TA 1535, TA 1537, TA 98 and TA 100
- Metabolic activation:
- with and without
- Metabolic activation system:
- S9 mix (rat liver supernatant from rats treated with Aroclor 1254)
- Test concentrations with justification for top dose:
- Without and without metabolic activation: 4, 20, 100, 500, 2500, 5000 μg/plate in both experiments.
- Vehicle / solvent:
- - Vehicle(s)/solvent(s) used: DMSO;
The test compound did not precipitate on the plates up to the highest investigated dose of 5000 μg/plate.
Controls
- Untreated negative controls:
- yes
- Negative solvent / vehicle controls:
- yes
- True negative controls:
- no
- Positive controls:
- yes
- Positive control substance:
- 9-aminoacridine
- 2-nitrofluorene
- sodium azide
- other: 2-aminoanthracene
- Details on test system and experimental conditions:
- METHOD OF APPLICATION: in agar (plate incorporation)
SELECTION AGENT (mutation assays): histidine (in agar)
NUMBER OF REPLICATIONS:
1st experiment: Triplicates (3 plates per dose)
2nd experiment: Triplicates (3 plates per dose)
DETERMINATION OF CYTOTOXICITY
A reduced rate of spontaneously occurring colonies and visible thinning of the bacterial lawn were used as toxicity indicators. Thinning of the bacterial lawn was evaluated microscopically.
Parallel to the 2nd experiment, precise toxicity testing was performed: 0.1 mL of the different concentrations of the test compound were thoroughly mixed with 0.1 mL of 1.0E+07 dilution of the overnight culture of TA 100 (designated TA 100D) and plated with histidine and biotin rich top agar (3 plates per dose). The solvent control was compared with the number of colonies per plate in the presence of the test compound. Results were given as a ratio of these values (= surviving fraction).
- OTHER:
The strains of Salmonella typhimurium were obtained from Professor B.N. Ames, University of California, U.S.A..
The different bacterial strains were checked half-yearly with regard to their respective biotin, histidine requirements, membrane permeability, ampicillin resistance, crystal violet sensitivity, UV resistance and response to diagnostic mutagens.
Results and discussion
Test results
- Key result
- Species / strain:
- S. typhimurium, other: TA 100, TA 1535, TA 1537, TA 98
- Metabolic activation:
- with and without
- Genotoxicity:
- negative
- Cytotoxicity / choice of top concentrations:
- cytotoxicity
- Remarks:
- at ≥2500 µg/plate
- Vehicle controls validity:
- valid
- Untreated negative controls validity:
- valid
- Positive controls validity:
- valid
- Additional information on results:
- In the toxicity test using histidine enriched agar plates and a dilution of the tester strain TA 100 (designated TA 100 D), which was performed in parallel with the second experiment, toxicity was found at concentrations of 2500 μg/plate and above in the absence of metabolic activation and 5000 μg/plate in the presence of metabolic activation.
Any other information on results incl. tables
Table 1: Results of first experiment (number of revertants)
|
|
plate 1 |
plate 2 |
plate 3 |
Bacterial lawn |
|
|
|
|
|
|
TA 100 |
Solvent control |
137 |
145 |
146 |
|
with S9 |
Negative control |
145 |
170 |
160 |
|
|
4 µg/plate |
143 |
151 |
147 |
|
|
20 µg/plate |
151 |
145 |
99 |
|
|
100 µg/plate |
136 |
153 |
145 |
|
|
500 µg/plate |
136 |
138 |
145 |
|
|
2500 µg/plate |
124 |
140 |
130 |
|
|
5000 µg/plate |
153 |
162 |
139 |
incomplete |
|
2-aminoanthracene (0.5 µg/plate) |
942 |
914 |
1052 |
|
|
|
|
|
|
|
TA 100 |
Solvent control |
148 |
133 |
129 |
|
without S9 |
Negative control |
170 |
165 |
146 |
|
|
4 µg/plate |
129 |
116 |
146 |
|
|
20 µg/plate |
145 |
142 |
119 |
|
|
100 µg/plate |
118 |
134 |
145 |
|
|
500 µg/plate |
134 |
147 |
144 |
|
|
2500 µg/plate |
110 |
126 |
110 |
|
|
5000 µg/plate |
111 |
76 |
84 |
|
|
sodium azide (1.0 µg/plate) |
634 |
718 |
652 |
incomplete |
|
|
|
|
|
|
TA 1535 |
Solvent control |
17 |
15 |
20 |
|
with S9 |
Negative control |
9 |
14 |
12 |
|
|
4 µg/plate |
11 |
10 |
16 |
|
|
20 µg/plate |
17 |
11 |
11 |
|
|
100 µg/plate |
12 |
11 |
11 |
|
|
500 µg/plate |
16 |
15 |
12 |
|
|
2500 µg/plate |
10 |
7 |
13 |
incomplete |
|
5000 µg/plate |
8 |
11 |
7 |
incomplete |
|
2-aminoanthracene (1.0 µg/plate) |
129 |
125 |
143 |
|
|
|
|
|
|
|
TA 1535 |
Solvent control |
10 |
13 |
11 |
|
without S9 |
Negative control |
9 |
12 |
12 |
|
|
4 µg/plate |
14 |
12 |
12 |
|
|
20 µg/plate |
10 |
11 |
14 |
|
|
100 µg/plate |
10 |
10 |
10 |
|
|
500 µg/plate |
11 |
8 |
14 |
|
|
2500 µg/plate |
6 |
8 |
10 |
incomplete |
|
5000 µg/plate |
3 |
4 |
5 |
incomplete |
|
sodium azide (1.0 µg/plate) |
385 |
545 |
415 |
|
|
|
|
|
|
|
TA 1537 |
Solvent control |
10 |
7 |
11 |
|
with S9 |
Negative control |
8 |
9 |
12 |
|
|
4 µg/plate |
9 |
9 |
8 |
|
|
20 µg/plate |
7 |
10 |
10 |
|
|
100 µg/plate |
7 |
6 |
8 |
|
|
500 µg/plate |
8 |
8 |
6 |
incomplete |
|
2500 µg/plate |
6 |
2 |
5 |
incomplete |
|
5000 µg/plate |
3 |
1 |
2 |
incomplete |
|
2-aminoanthracene (1.0 µg/plate) |
125 |
137 |
184 |
|
|
|
|
|
|
|
TA 1537 |
Solvent control |
6 |
7 |
7 |
|
without S9 |
Negative control |
9 |
10 |
7 |
|
|
4 µg/plate |
6 |
9 |
8 |
|
|
20 µg/plate |
8 |
6 |
9 |
|
|
100 µg/plate |
6 |
9 |
7 |
|
|
500 µg/plate |
4 |
8 |
10 |
|
|
2500 µg/plate |
8 |
3 |
8 |
incomplete |
|
5000 µg/plate |
8 |
4 |
4 |
incomplete |
|
9-aminoacridine (50 µg/plate) |
236 |
117 |
118 |
|
|
|
|
|
|
|
TA98 |
Solvent control |
21 |
28 |
21 |
|
with S9 |
Negative control |
28 |
29 |
29 |
|
|
4 µg/plate |
25 |
33 |
30 |
|
|
20 µg/plate |
27 |
31 |
30 |
|
|
100 µg/plate |
32 |
25 |
32 |
|
|
500 µg/plate |
29 |
32 |
28 |
|
|
2500 µg/plate |
22 |
24 |
34 |
incomplete |
|
5000 µg/plate |
28 |
13 |
13 |
incomplete |
|
2-aminoanthracene (0.5 µg/plate) |
1212 |
1213 |
1292 |
|
|
|
|
|
|
|
TA98 |
Solvent control |
26 |
21 |
22 |
|
without S9 |
Negative control |
27 |
23 |
24 |
|
|
4 µg/plate |
21 |
19 |
21 |
|
|
20 µg/plate |
28 |
22 |
18 |
|
|
100 µg/plate |
18 |
17 |
24 |
|
|
500 µg/plate |
24 |
22 |
19 |
|
|
2500 µg/plate |
18 |
9 |
18 |
incomplete |
|
5000 µg/plate |
7 |
5 |
7 |
incomplete |
|
2-nitrofluorene (2.5 µg/plate) |
220 |
336 |
265 |
|
Table 2: Results of second experiment (number of revertants)
|
|
plate 1 |
plate 2 |
plate 3 |
Bacterial lawn |
|
|
|
|
|
|
TA 100 |
Solvent control |
141 |
150 |
144 |
|
with S9 |
Negative control |
134 |
144 |
145 |
|
|
4 µg/plate |
140 |
123 |
133 |
|
|
20 µg/plate |
123 |
139 |
130 |
|
|
100 µg/plate |
121 |
150 |
145 |
|
|
500 µg/plate |
137 |
158 |
155 |
|
|
2500 µg/plate |
130 |
130 |
120 |
|
|
5000 µg/plate |
119 |
143 |
155 |
|
|
2-aminoanthracene (0.5 µg/plate) |
1550 |
1514 |
1562 |
|
|
|
|
|
|
|
TA 100 |
Solvent control |
127 |
122 |
138 |
|
without S9 |
Negative control |
173 |
162 |
141 |
|
|
4 µg/plate |
117 |
139 |
146 |
|
|
20 µg/plate |
135 |
136 |
132 |
|
|
100 µg/plate |
124 |
130 |
141 |
|
|
500 µg/plate |
116 |
130 |
120 |
|
|
2500 µg/plate |
110 |
112 |
117 |
|
|
5000 µg/plate |
87 |
80 |
76 |
|
|
sodium azide (1.0 µg/plate) |
682 |
704 |
685 |
|
|
|
|
|
|
|
TA 1535 |
Solvent control |
15 |
9 |
10 |
|
with S9 |
Negative control |
11 |
14 |
15 |
|
|
4 µg/plate |
14 |
12 |
9 |
|
|
20 µg/plate |
11 |
14 |
11 |
|
|
100 µg/plate |
8 |
10 |
12 |
|
|
500 µg/plate |
11 |
14 |
12 |
|
|
2500 µg/plate |
14 |
12 |
16 |
|
|
5000 µg/plate |
12 |
10 |
9 |
|
|
2-aminoanthracene (1.0 µg/plate) |
160 |
145 |
193 |
|
|
|
|
|
|
|
TA 1535 |
Solvent control |
14 |
14 |
10 |
|
without S9 |
Negative control |
14 |
8 |
8 |
|
|
4 µg/plate |
9 |
10 |
10 |
|
|
20 µg/plate |
9 |
15 |
11 |
|
|
100 µg/plate |
11 |
14 |
12 |
|
|
500 µg/plate |
11 |
14 |
14 |
|
|
2500 µg/plate |
12 |
14 |
9 |
|
|
5000 µg/plate |
3 |
2 |
4 |
incomplete |
|
sodium azide (1.0 µg/plate) |
464 |
426 |
424 |
|
|
|
|
|
|
|
TA 1537 |
Solvent control |
7 |
11 |
10 |
|
with S9 |
Negative control |
7 |
9 |
8 |
|
|
4 µg/plate |
8 |
7 |
10 |
|
|
20 µg/plate |
10 |
11 |
8 |
|
|
100 µg/plate |
11 |
6 |
6 |
|
|
500 µg/plate |
8 |
7 |
8 |
|
|
2500 µg/plate |
10 |
10 |
8 |
|
|
5000 µg/plate |
5 |
3 |
3 |
incomplete |
|
2-aminoanthracene (1.0 µg/plate) |
207 |
253 |
256 |
|
|
|
|
|
|
|
TA 1537 |
Solvent control |
8 |
8 |
6 |
|
without S9 |
Negative control |
10 |
6 |
9 |
|
|
4 µg/plate |
10 |
6 |
10 |
|
|
20 µg/plate |
8 |
9 |
6 |
|
|
100 µg/plate |
9 |
8 |
14 |
|
|
500 µg/plate |
7 |
10 |
9 |
|
|
2500 µg/plate |
4 |
6 |
9 |
incomplete |
|
5000 µg/plate |
3 |
2 |
1 |
incomplete |
|
9-aminoacridine (50 µg/plate) |
149 |
16 |
139 |
|
|
|
|
|
|
|
TA98 |
Solvent control |
44 |
31 |
33 |
|
with S9 |
Negative control |
45 |
26 |
38 |
|
|
4 µg/plate |
22 |
29 |
30 |
|
|
20 µg/plate |
29 |
31 |
35 |
|
|
100 µg/plate |
30 |
24 |
38 |
|
|
500 µg/plate |
37 |
30 |
41 |
|
|
2500 µg/plate |
20 |
23 |
30 |
|
|
5000 µg/plate |
14 |
20 |
19 |
incomplete |
|
2-aminoanthracene (0.5 µg/plate) |
2007 |
1917 |
1933 |
|
|
|
|
|
|
|
TA98 |
Solvent control |
24 |
27 |
27 |
|
without S9 |
Negative control |
22 |
23 |
26 |
|
|
4 µg/plate |
28 |
21 |
34 |
|
|
20 µg/plate |
36 |
34 |
34 |
|
|
100 µg/plate |
26 |
28 |
25 |
|
|
500 µg/plate |
32 |
33 |
24 |
|
|
2500 µg/plate |
19 |
11 |
16 |
incomplete |
|
5000 µg/plate |
5 |
6 |
8 |
incomplete |
|
2-nitrofluorene (2.5 µg/plate) |
777 |
756 |
765 |
|
Applicant's summary and conclusion
- Conclusions:
- CLP/EU GHS criteria not met, no classification required according to Regulation (EC) No 1272/2008.
Information on Registered Substances comes from registration dossiers which have been assigned a registration number. The assignment of a registration number does however not guarantee that the information in the dossier is correct or that the dossier is compliant with Regulation (EC) No 1907/2006 (the REACH Regulation). This information has not been reviewed or verified by the Agency or any other authority. The content is subject to change without prior notice.
Reproduction or further distribution of this information may be subject to copyright protection. Use of the information without obtaining the permission from the owner(s) of the respective information might violate the rights of the owner.
![ECHA](/o/diss-blank-theme/images/factsheets/A-REACH/factsheet/echa_logo.png)